Phase I/II Study of the Novel Combination of Panobinostat (LBH589) and Everolimus (RAD001) In Relapsed/Refractory Hodgkin and Non-Hodgkin Lymphoma

被引：1
作者：
Younes, Anas [1 ]
Copeland, Amanda [2 ]
Fanale, Michelle A. [3 ]
Hagemeister, Fredrick [4 ]
Fayad, Luis [5 ]
Pro, Barbara [6 ]
Faria, Silvana C.
Ji, Yuan [7 ]
Medeiros, L. Jeffrey
Berry, Donald A.
Buglio, Daniela [4 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Clin Invest & Translat Res Dept Lymphoma Myeloma, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, MD Anderson Canc Ctr Hymphoma Myeloma, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, MD Anderson Canc Ctr Lymphoma Myeloma, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
[6] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[7] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Div Quantitat Sci, Houston, TX 77030 USA
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
10.1182/blood.V116.21.1763.1763
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1617 / 1617
页数：1
相关论文
共 50 条
  • [41] Phase II trial for lenalidomide alone in relapsed/refractory aggressive non-Hodgkin lymphoma
    不详
    CLINICAL LYMPHOMA & MYELOMA, 2007, 7 (05) : 339 - 339
  • [42] Phase I Study of Panobinostat plus Everolimus in Patients with Relapsed or Refractory Lymphoma
    Oki, Yasuhiro
    Buglio, Daniela
    Fanale, Michelle
    Fayad, Luis
    Copeland, Amanda
    Romaguera, Jorge
    Kwak, Larry W.
    Pro, Barbara
    Faria, Silvana de Castro
    Neelapu, Sattva
    Fowler, Nathan
    Hagemeister, Fredrick
    Zhang, Jiexin
    Zhou, Shouhao
    Feng, Lei
    Younes, Anas
    CLINICAL CANCER RESEARCH, 2013, 19 (24) : 6882 - 6890
  • [43] PANORAMA 2: A phase II study of panobinostat (LBH589) in combination with bortezomib (BTZ) and dexamethasone (DEX) in patients with relapsed and BTZ-refractory multiple myeloma (MM)
    Alsina, M.
    Lonial, S.
    Weber, D. M.
    Coutre, S. E.
    Kang, B. P.
    Glynos, T.
    Warsi, G.
    Snodgrass, S. M.
    Richardson, P. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [44] A Phase I Study of Panobinostat in Combination With ICE (Ifosfamide, Carboplatin and Etoposide) in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (cHL)
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2014, 12 (02) : 5 - 6
  • [45] A phase II study of gemcitabine in patients with relapsed or refractory low-grade non-hodgkin lymphoma
    Larson, BJG
    Waples, JM
    Pusateri, A
    Mendenhall, NP
    Lynch, JW
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (02): : 165 - 168
  • [46] A Phase I Study Of Panobinostat In Combination With ICE (Ifosfamide, Carboplatin and Etoposide) In Patients With Relapsed Or Refractory Classical Hodgkin Lymphoma (cHL)
    Oki, Yasuhiro
    Fanale, Michelle A.
    Westin, Jason R.
    Fowler, Nathan
    Neelapu, Sattva S.
    Hagemeister, Fredrick B.
    Rodriguez, Maria Alma
    Younes, Anas
    BLOOD, 2013, 122 (21)
  • [47] A phase II study of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed or refractory non-Hodgkin lymphoma
    Ikoma, Yoshikazu
    Nakamura, Nobuhiko
    Kitagawa, Junichi
    Miwa, Takao
    Takada, Eri
    Matsumoto, Takuro
    Shibata, Yuhei
    Nakamura, Hiroshi
    Kanemura, Nobuhiro
    Kasahara, Senji
    Hara, Takeshi
    Sawada, Michio
    Tsurumi, Hisashi
    Shimizu, Masahito
    HEMATOLOGICAL ONCOLOGY, 2024, 42 (01)
  • [48] Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
    Davids, Matthew S.
    Roberts, Andrew W.
    Seymour, John F.
    Pagel, John M.
    Kahl, Brad S.
    Wierda, William G.
    Puvvada, Soham
    Kipps, Thomas J.
    Anderson, Mary Ann
    Salem, Ahmed Hamed
    Dunbar, Martin
    Zhu, Ming
    Peale, Franklin
    Ross, Jeremy A.
    Gressick, Lori
    Desai, Monali
    Kim, Su Young
    Verdugo, Maria
    Humerickhouse, Rod A.
    Gordon, Gary B.
    Gerecitano, John F.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (08) : 826 - 833
  • [49] Phase I/II study of pixantrone in combination with cyclophosphamide, vincristine, and prednisone in patients with relapsed aggressive non-Hodgkin lymphoma
    Borchmann, Peter
    Herbrecht, Raoul
    Wilhelm, Martin
    Morschhauser, Franck
    Hess, Georg
    Cernohous, Paul
    Veals, Susan A.
    Singer, Jack W.
    Engert, Andreas
    LEUKEMIA & LYMPHOMA, 2011, 52 (04) : 620 - 628
  • [50] Phase I Study of the Combination of Bendamustine, Rituximab, and Pixantrone in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
    Heyman, Benjamin
    Rizzieri, David
    Adams, David J.
    De Castro, Carlos
    Diehl, Louis
    Li, Zhiguo
    Moore, Joseph
    Beaven, Anne
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (10) : 679 - 686
12345